E. Ozbek Et Al. , "Atorvastatin Prevents Gentamicin-Induced Renal Damage in Rats through the Inhibition of p38-MAPK and NF-kB Pathways," RENAL FAILURE , vol.31, no.5, pp.382-392, 2009
Ozbek, E. Et Al. 2009. Atorvastatin Prevents Gentamicin-Induced Renal Damage in Rats through the Inhibition of p38-MAPK and NF-kB Pathways. RENAL FAILURE , vol.31, no.5 , 382-392.
Ozbek, E., Cekmen, M., Ilbey, Y. O., Simsek, A., POLAT, E., & Somay, A., (2009). Atorvastatin Prevents Gentamicin-Induced Renal Damage in Rats through the Inhibition of p38-MAPK and NF-kB Pathways. RENAL FAILURE , vol.31, no.5, 382-392.
Ozbek, Emin Et Al. "Atorvastatin Prevents Gentamicin-Induced Renal Damage in Rats through the Inhibition of p38-MAPK and NF-kB Pathways," RENAL FAILURE , vol.31, no.5, 382-392, 2009
Ozbek, Emin Et Al. "Atorvastatin Prevents Gentamicin-Induced Renal Damage in Rats through the Inhibition of p38-MAPK and NF-kB Pathways." RENAL FAILURE , vol.31, no.5, pp.382-392, 2009
Ozbek, E. Et Al. (2009) . "Atorvastatin Prevents Gentamicin-Induced Renal Damage in Rats through the Inhibition of p38-MAPK and NF-kB Pathways." RENAL FAILURE , vol.31, no.5, pp.382-392.
@article{article, author={Emin Ozbek Et Al. }, title={Atorvastatin Prevents Gentamicin-Induced Renal Damage in Rats through the Inhibition of p38-MAPK and NF-kB Pathways}, journal={RENAL FAILURE}, year=2009, pages={382-392} }